Earnings call briefThird-quarter 2026
Danaher DHR
Danaher says it is planning $1.5 billion of respiratory revenue this year
The company said 4% to 5% core revenue growth, excluding respiratory revenue, is the right starting point for 2027, with a more quantitative outlook to follow in January.
GetSignal
President and Chief Executive Officer Julie Sawyer Montgomery said on the third-quarter call that the company is planning for $1.5 billion of respiratory revenue this year to reflect a middle-of-the-road flu season.
She said the same $1.5 billion is also the right starting point for next year.
Quotes from the call
“As we look to 2027, we think that 4%-5% core revenue growth, excluding respiratory revenue, is the right starting point as we sit today.”
Key facts from the call
- Planned 2026 respiratory revenue
- $1.5 billion
- Expected 2027 core revenue growth starting point
- 4% to 5%, excluding respiratory revenue
- Expected timing of quantitative 2027 outlook
- January
Source: Danaher's third-quarter 2026 earnings call, October 21, 2026.
Written by GetSignal with AI from the company's earnings call. How we make news
Not investment advice.
More earnings call briefs
The newest- DPC Holdings raises 2026 guidance and sets 2027 outlook
DPC · DPC Holdings · Q3 2026 call · Nov 12, 2026
- Enhanced Group expects its sports business to break even or better in 2027
ENHA · Enhanced Group Inc. Class A · Q3 2026 call · Nov 12, 2026
- Cerebras Systems says hardware mix will be closer to 50% in fourth quarter
CBRS · Cerebras Systems · Q3 2026 call · Nov 12, 2026
- Nu Holdings now expects a 2026 efficiency ratio of 19% to 19.5%
NU · Nu Holdings · Q3 2026 call · Nov 12, 2026
